vTv Therapeutics Inc. Proceeds from Notes Payable
vTv Therapeutics Inc. (VTVT) reported Proceeds from Notes Payable of $392.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-03-10
- vTv Therapeutics Inc. proceeds from notes payable for the quarter ending 2024-12-31 was $0.00.
- vTv Therapeutics Inc. proceeds from notes payable for the quarter ending 2023-12-31 was $0.00.
- vTv Therapeutics Inc. proceeds from notes payable for the quarter ending 2021-12-31 was $0.00.
- vTv Therapeutics Inc. proceeds from notes payable for the quarter ending 2020-12-31 was $0.00.
- vTv Therapeutics Inc. proceeds from notes payable for fiscal 2025 was $392.00K.
- vTv Therapeutics Inc. proceeds from notes payable for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- vTv Therapeutics Inc. proceeds from notes payable for fiscal 2023 was $566.00K, a 27.06% decline from fiscal 2022.
- vTv Therapeutics Inc. proceeds from notes payable for fiscal 2022 was $776.00K, a 12.51% decline from fiscal 2021.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2025-12-31 | $392.00K 10-K · filed 2026-03-10 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $566.00K 10-K · filed 2026-03-10 | |
| 2023-09-30 | $566.00K 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | $776.00K 10-K · filed 2025-03-20 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $887.00K 10-K · filed 2024-03-13 | |
| 2021-09-30 | $887.00K 10-Q · filed 2021-11-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $500.00K 10-K · filed 2023-03-06 | |
| 2020-09-30 | $500.00K 10-Q · filed 2021-11-09 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $500.00K 10-K · filed 2022-03-29 | |
| 2019-09-30 | $500.00K 10-Q · filed 2020-11-05 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $500.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | $500.00K 10-Q · filed 2019-10-30 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $7.50M 10-K · filed 2020-02-21 | |
| 2017-09-30 | $7.50M 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | $12.50M 10-K · filed 2019-02-26 |